Key statistics
On Tuesday, Innate Pharma SA (IPHA:NSQ) closed at 2.14, 18.23% above the 52 week low of 1.81 set on Nov 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.09 |
---|---|
High | 2.14 |
Low | 2.07 |
Bid | 2.07 |
Offer | 2.10 |
Previous close | 2.06 |
Average volume | 12.32k |
---|---|
Shares outstanding | 80.97m |
Free float | 62.13m |
P/E (TTM) | -- |
Market cap | 173.44m USD |
EPS (TTM) | -0.4628 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 19:57 BST.
More ▼
Press releases
- Innate Pharma to Host KOL Scientific Symposium on Immunotherapy in New York on October 3, 2024
- Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be Developed in Solid Tumors
- Innate Pharma Reports First Half 2024 Business Update and Financial Results
- Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024
- Innate Pharma Announces Conference Call and Webcast for First Half 2024 Financial Results and Business Update
- Innate Pharma Announces Its Participation in the H.C. Wainwright 26th Annual Global Investment Conference
- Innate Pharma Announces Its Participation in Upcoming Investor Conference
- Number of Shares and Voting Rights of Innate Pharma as of July 10, 2024
More ▼